MEDICAMEN BIOTECH
Back to Income Statement
|
MEDICAMEN BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹15 Cr | ₹15 Cr | ₹1,212,944 Cr | ₹13 Cr | ₹12 Cr |
What is the latest Consolidated Net Profit of MEDICAMEN BIOTECH ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹15 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹1,212,944 Cr |
Mar2021 | ₹13 Cr |
Mar2020 | ₹12 Cr |
How is Consolidated Net Profit of MEDICAMEN BIOTECH Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹15 Cr | -1.13 | |
Mar2023 | ₹15 Cr | -100.00 | |
Mar2022 | ₹1,212,944 Cr | 9,125,955.15 | |
Mar2021 | ₹13 Cr | 10.52 | |
Mar2020 | ₹12 Cr | - |
Compare Consolidated Net Profit of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹528.1 Cr | -0.2% | -4% | -9.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,219.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,227.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,643.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹125,541.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,063.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | -0.2% |
-4% |
-9.4% |
SENSEX | -1.2% |
-3% |
-0.2% |
You may also like the below Video Courses